|本期目录/Table of Contents|

[1]戴志莲,朱立勤,岳志华,等.基于自发呈报系统的异烟肼与解热镇痛药联用的肝损害风险对比[J].天津医科大学学报,2020,26(06):560-562.
 DAI Zhi-lian,ZHU Li-qin,YUE Zhi-hua,et al.Comparison of the risk of liver injury caused by isoniazid combined with antipyretic analgesics based on the spontaneous reporting system[J].Journal of Tianjin Medical University,2020,26(06):560-562.
点击复制

基于自发呈报系统的异烟肼与解热镇痛药联用的肝损害风险对比(PDF)
分享到:

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
26卷
期数:
2020年06期
页码:
560-562
栏目:
临床医学
出版日期:
2020-11-20

文章信息/Info

Title:
Comparison of the risk of liver injury caused by isoniazid combined with antipyretic analgesics based on the spontaneous reporting system
作者:
戴志莲12朱立勤3岳志华4周畅2
1.天津医科大学一中心临床学院,天津300192;2.天津市海河医院药剂科,天津300350;3.天津市第一中心医院药剂科,天津300192;4.国家药典委员会,北京100061
Author(s):
DAI Zhi-lian12 ZHU Li-qin3 YUE Zhi-hua4 ZHOU Chang2
1.The First Central Clinical College,Tianjin Medical University,Tianjin 300192,China; 2.Department of Pharmacy,Tianjin Haihe Hospital,Tianjin 300350,China; 3.Department of Pharmacy,Tianjin First Central Hospital,Tianjin 300192,China; 4.Chinese Pharmacopoeia Commission,Beijing 100061,China
关键词:
异烟肼对乙酰氨基酚洛索洛芬肝损害
Keywords:
isoniazidacetaminophenloxoprofenliver injury
分类号:
R971+.1
DOI:
-
文献标志码:
A
摘要:
目的:比较异烟肼(INH)分别与两种解热镇痛药联用发生肝损害的风险,为临床用药提供参考。方法:选取美国不良反应自发呈报系统数据,研究病例被设置为两个观察组[INH联合洛索洛芬(LOX)和INH联合对乙酰氨基酚(APAP)]以及对照组(单用INH)。观察组和对照组通过报告比值比(ROR)法进行比较,同时应用比值比(OR)评价各组发生肝损害风险。结果:本研究共纳入17 930例事件报告,组间发生肝损害风险差异有统计学意义(P<0.001)。经过年龄、性别和报告年份校正后,与单用INH相比,INH联合LOX发生肝损害OR值为28.057(95%CI:22.783~34.553),联合APAP的OR值为92.551(95%CI:74.283~115.312)。年龄的OR值为0.988(95%CI:0.986~0.991);女性的OR值是0.714(95%CI:0.647~0.789)。结论:INH联合LOX肝损害发生风险低于INH联合APAP;女性和年长者发生肝损害风险可能更低。
Abstract:
Objective: To compare the risk of liver injury caused by the combination of isoniazid(INH) and two kinds of antipyretic analgesics,respectively,and to provide references for clinical medication. Methods: The data was selected from the spontaneous reporting system for adverse reactions in the United States. The research cases were divided into two observation groups[the combination of INH and loxoprofen(LOX) and the combination of INH and acetaminophen(APAP)] and a control group (only INH). The two observation groups were compared with the control group by applying reporting odds ratios(ROR).The OR was adopted to evaluate the risk of liver injury in every group. Results: In total,17 930 reports were included in the study. In terms of the risk of liver injury among groups,there existed statistically significant differences(P<0.001).After adjusting age,gender and reporting years,compared with INH alone,the OR of liver injury caused by the combination of INH and LOX was 28.057(95%CI:22.783-34.553),the OR of the combination of INH and APAP was 92.551(95%CI:74.283-115.312). The OR of age was 0.988(95%CI:0.986-0.991),the OR of female was 0.714(95%CI:0.647-0.789). Conclusion: The combination of INH and LOX has a lower risk of liver injury than the combination of INH and APAP. Female and the elderly have a lower risk of liver injury.

参考文献/References:

[1] European Regional Certification Commission for Poliomyelitis Eradication. Meeting (21st : 2008 : Copenhagen,Denmark). Guidelines on the Management of Latent Tuberculosis Infection[J]. Thorax, 2015,67(12):1121
[2] 中国防痨协会. 耐药结核病化学治疗指南(2015)[J]. 中国防痨杂志,2015,37(5):421
[3] 罗博文,李善瑞,宋钰珺,等. 基于美国FAERS数据库的尼拉帕利不良事件数据挖掘研究[J]. 肿瘤药学,2020 ,10(3):313
[4] 吴斌,吴逢波,田方圆,等. 基于FAERS的α_(1)受体拮抗剂相关性功能障碍不良事件数据挖掘研究[J/OL]. 中国医院药学杂志:1-7
[2020-07-30].http://kns.cnki.net/kcms/detail/42.1204.R.20200706.1118.012.html
[5] 王程程,彭媛,唐利,等. 舒尼替尼上市后肝损害的信号检测与分析[J]. 中国医院药学杂志,2013,33(23) :1981
[6] Suzuki A,Yuen N A,Ilic K,et al. Comedications alter drug-induced liver injury reporting frequency:data mining in the WHO VigiBaseTM[J]. Regul Toxicol Pharmacol,2015,72(3):481
[7] 李苑雅,张艳,沈爱宗. 基于自发呈报系统药品不良反应信号检测方法的研究进展[J] . 安徽医药,2015,19 (7):1233
[8] Ali A K,Hartzema A G. Assessing the association between omalizumab and arteriothrombotic events through spontaneous adverse event reporting[J]. J Asthma Allergy,2012,5:1
[9] 于乐成,茅益民,陈成伟. 药物性肝损伤诊治指南[J]. 肝脏,2015,23(10):1752
[10] 中华医学会结核病学分会. 抗结核药所致药物性肝损伤诊断与处理专家建议[J]. 中华结核和呼吸杂志,2013, 36(10):732
[11] Principi N,Galli L,Lancella L,et al. Recommendations concerning the first-line treatment of children with tuberculosis[J]. Paediatr Drugs,2016,18(1):13
[12] 陈成伟,马洪年,傅青青,等. 药物与中毒性肝病[M]. 第2版.上海:上海科学技术出版社,2013: 365-647
[13] Lapeyre-Mestre M,de Castro A M,Bareille M P,et al. Non-steroidal anti-inflammatory drug-related hepatic damage in France and Spain: analysis from national spontaneous reporting systems[J]. Fundam Clin Pharmacol,2006,20(4):391
[14] 兰茜,王胜锋,翟所迪,等. 采用报告比值比法挖掘非甾体抗炎药相关肝损伤信号[J]. 药物不良反应杂志, 2014,16(3):143
[15] Schiff E R,Maddrey W C,Sorrell M.希夫肝脏病学[M].王福生,译.北京:北京大学医学出版社,2015
[16] 汪倩,徐瑞娟,杨劲. 对乙酰氨基酚肝毒性机理及药物干预靶点[J]. 药学与临床研究,2011,19(3):247
[17] 乐江. CYP2E1介导异烟肼肝毒作用机制及其有效干预措施研究[D]. 武汉大学,2004
[18] Thummel K E,Slattery J T,Ro H,et al. Ethanol and production of the hepatotoxic metabolite of acetaminophen in healthy adults[J]. Clin Pharmacol Ther,2000,67(6):591

相似文献/References:

[1]崔润丽.基于FAERS的对乙酰氨基酚药物不良反应性别差异信号分析[J].天津医科大学学报,2024,30(01):79.[doi:10.20135/j.issn.1006-8147.2024.01.0079]
 CUI Runli.Gender differences in adverse drug reaction signals of acetaminophen medications based on FAERS analysis[J].Journal of Tianjin Medical University,2024,30(06):79.[doi:10.20135/j.issn.1006-8147.2024.01.0079]

备注/Memo

备注/Memo:
文章编号 1006-8147(2020)06-0560-03
作者简介 戴志莲(1987-),女,主管药师,硕士在读,研究方向:临床药学;通信作者: 朱立勤,E-mail:zlq0713@aliyun.com。
更新日期/Last Update: 2020-11-20